# Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF

> **NCT05330312** · NA · COMPLETED · sponsor: **Vicore Pharma AB** · enrollment: 119 (actual)

## Conditions studied

- Pulmonary Fibrosis
- Anxiety

## Interventions

- **DEVICE:** Digital cognitive behavioral therapy

## Key facts

- **NCT ID:** NCT05330312
- **Lead sponsor:** Vicore Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-17
- **Primary completion:** 2023-10-19
- **Final completion:** 2023-11-10
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2024-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05330312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05330312, "Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05330312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*